Exploring daily movement behaviors in patients with type 2 diabetes

24-hour Movement Behaviors Among Type 2 Diabetes Mellitus Patients

University Hospital, Ghent · NCT04993482

This study looks at how people with type 2 diabetes move throughout the day to see how their activity levels affect their health and to help create better lifestyle tips for managing the condition.

Quick facts

Study typeObservational
Enrollment248 (estimated)
Ages18 Years to 100 Years
SexAll
SponsorUniversity Hospital, Ghent (other)
Locations1 site (Ghent)
Trial IDNCT04993482 on ClinicalTrials.gov

What this trial studies

This observational study investigates the 24-hour movement behavior patterns among patients with type 2 diabetes mellitus (T2DM) over a two-year period. It compares these patterns with a healthy control group and examines associations with personal and environmental factors, as well as cardiometabolic markers. The goal is to gain insights into how different movement behaviors impact T2DM management and to lay the groundwork for future interventions. By understanding these behaviors collectively rather than in isolation, the study aims to inform better lifestyle recommendations for T2DM patients.

Who should consider this trial

Good fit: Ideal candidates for this study are adults over 18 years old diagnosed with type 2 diabetes mellitus.

Not a fit: Patients with type 1 diabetes, certain physical or cognitive disabilities, or other severe health conditions may not benefit from this study.

Why it matters

Potential benefit: If successful, this study could lead to improved lifestyle recommendations that enhance the management of type 2 diabetes.

How similar studies have performed: Other studies have shown success in examining lifestyle behaviors in diabetes management, but this comprehensive 24-hour approach is relatively novel.

Eligibility criteria

Show full inclusion / exclusion criteria
Inclusion criteria T2DM patients

* Adults aged \>18 years old
* Diagnosed with T2DM by a physician or an HbA1C above 6.5%

Exclusion criteria T2DM patients

* Diagnosed with type 1 diabetes mellitus (T1DM)
* Diagnosed with pregnancy diabetes
* Diagnosed with latent autoimmune diabetes in adults (LADA)
* Physical disabilities that obstruct the normal PA pattern (e.g. amputations, paralysis)
* Cognitive disabilities that obstruct daily functioning (e.g. dementia, psychological disorders)
* Other conditions affecting the normal PA pattern (e.g. heart failure NYHA class 3 and 4, chronic respiratory diseases (COPD stage 4), end stage nonalcoholic fatty liver disease, end stage renal failure, cancer, hospitalized)
* Pregnancy or pregnancy \<1 year ago
* Participating in a physical activity intervention

Inclusion criteria control participants

\- Adults aged \> 18 years old

Exclusion criteria control participants

* Diagnosed with T2DM
* Diagnosed with T1DM
* Diagnosed with pregnancy diabetes
* Diagnosed with LADA
* Physical disabilities that obstruct the normal PA pattern (e.g. amputations, paralysis)
* Cognitive disabilities that obstruct daily functioning (e.g. dementia, psychological disorders)
* Other conditions affecting the normal PA pattern (e.g. heart failure NYHA class 3 and 4, chronic respiratory diseases (COPD stage 4), end stage nonalcoholic fatty liver disease, end stage renal failure, cancer, hospitalized)
* Pregnancy or pregnancy \<1 year ago
* Participating in a physical activity intervention

Where this trial is running

Ghent

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.

View on ClinicalTrials.gov →

Conditions: Diabetes Mellitus, Type 2, physical activity, sedentary behavior, sleep

Last reviewed 2026-05-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.